Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020

WALTHAM, Mass., July 28, 2020 (GLOBE NEWSWIRE) — Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic fibrosis and other diseases caused by nonsense mutations limiting production of functional proteins, today announced that Dr. Gregory Williams, Chief Executive Officer of Eloxx, will make a presentation and host one-on-one meetings with investors at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020.

Bay Street News